T&R Biofab Co., Ltd.

₩1,723As of Sun 8 Nov 2026, 12:00 UTC
KOSDAQ:246710Healthcare
Country South Korea
PE (Fwd) •••
TSR 8Y CAGR (10.08%)
Div yield —
ROE (127.88%)
Medical Devices
Beta (5Y) 0.44
PE TTM —
TSR TTM (2.93%)
Mkt cap ₩82.12B
ROIC (5.41%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
₩1,747
1.37%
(72.59%)
Hold 9|3|11|8|10
4Q25
1Q26
2Q26
3Q26
Earnings per share₩
26.05
27.59
28.65
28.14
35.76%
36.83%
28.92%
20.34%
Revenue₩B
3.570
3.761
3.652
3.638
0.47%
8.58%
7.67%
3.99%
Peers (US$60.54M)
Cap (US$)
PE
47.51M
—
46.47M
6.569x
Capital
TTM
5Y
10Y
Leveragex
0.606
0.042
0.031
EBIT/Intx
0.951
0.318
0.275
Own earn%
(56.78)
(5.45)
(17.68)
Sh yield%
32.21
35.36
31.15
Owners
Insiders/Inst%
5.40
39.62
Short interest%
4.72
SBC / revenue%
2.22
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
20
Op margin range%
14–22
$1 testx
—
Incr. ROIC%
11